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Association Between Gelatinase Release and Increased Plasma Membrane
Expression of the Mol Glycoprotein
By Pamela R. Petrequin, Robert F. Todd Ill, Larry J. Devall, Laurence A. Boxer, and John T. Curnutte III
Mol , a glycoprotein heterodimer (gp 1 55,95) that functions
as an adhesion promoting molecule and as the C3bi recep-
tor of human myeloid cells, is expressed in increased
amounts in the plasma membrane after exposure of poly-
morphonuclear leukocytes (PMNs) to various stimuli. Pre-
vious studies have suggested that secondary granules
represent an intracellular pool of Mol that, upon degranu-
lation, fuse with the plasma membrane resulting in a
tenfold increase in surface expression of Mel . To deter-
mine the intracellular location of Mel , we monitored Mel
expression by immunofluorescence and compared it to the
release of myeloperoxidase (MPO. a marker for the pri-
mary granules), vitamin B12 binding protein (B12BP, second-
ary granules), and gelatinase (gelatinase-containing or-
ganelles) following exposure to various stimuli. Human
neutrophils stimulated with 20 mmol/L fluoride for 16
T HE SURFACE of human myeloid cells contains a
glycoprotein, Mol, a heterodimeric glycoprotein with
subunit molecular weights of 155 kD and 94 kD.’ Mol,
which is equivalent to glycoproteins termed elsewhere as
OKMI2 and Mac-l,3 serves as the receptor for C3bi-
opsonized particles.￿ In addition, the Mol glycoprotein also
plays a role in various aspects of cellular adhesion such as
adherence, spreading, chemotaxis,7 and PM N aggregation #{149}8
Upon exposure to various degranulating stimuli, the surface
expression of Moi increases by up to tenfold, as determined
by ‘ enhanced C3bi receptor activi-
ty,8”2 and PMN aggregation.5 This up-regulation of Moi
appears to be due to the translocation of a large intracellular
pool of the glycoprotein to the cell surface.9￿3 Evidence for
this intracellular location is twofold. First, permeabilized
PMNs stained with a fluorescent monoclonal antibody
(MoAb) directed against Mol show a diffuse granular
fluorescence pattern . ￿ ￿ Second, subcellular fractionation
studies show Mol to be present in the fraction enriched for
secondary granules as well as in the membrane fraction.9”#{176}’3
On the basis of these data it has been postulated that
degranulation in PMNs results in the translocation of the
secondary granule-associated Mol to the plasma membrane,
where it is then detected in increased amounts.9
While the above data support a secondary granule location
for the intracellular pool of Moi , several lines of experimen-
tal evidence suggest that this glycoprotein might be con-
tamed in yet another intracellular compartment. First, the
surface expression of Mol increases under conditions in
which primary and secondary granules are not released, such
as incubating cells in suspension at 37#{176} C.’#{176}”3”4 Second, a
population of “granules” has recently been described, the
gelatinase-containing organelles, that do exhibit this type of
lability when incubated at 37#{176} C.’5 Using gelatinase release
to monitor these organelles, Dewald et al demonstrated that
the gelatinase-containing organdIes fuse with the membrane
during warming of PMNs as well as during exposure to low
(chemotactic) concentrations of FMLP.’5 These experimen-
tal conditions caused little, if any, release of primary or
secondary granule contents.’4”5 Third, secondary granules
minutes exhibited a twofold increase in Mol expression
and gelatinase release but no enhanced release of primary
or secondary granular contents. In a similar fashion, incu-
bation of cells at 37’ C for five minutes with 7.5 x lO￿ to
1 0 -e mol/ I N-formyl-methionyl-leucyl-phenylalanine
(FMLP) resulted in significant increases in both surface
Mol expression (three- to fivefold) and gelatinase release
(five- to eightfold) without significant release of either
MPO or B12BP. In addition, both the fluoride and FMLP
experiments demonstrated that Mol up-modulation alone
is not sufficient to activate superoxide (02 ) production.
These data indicate that at least one intracellular storage
pool of Mol is the gelatinase-containing organelles and
that their fusion with the plasma membrane results in
increased expression of Mol on the cell surface.
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and gelatinase-containing organelles have nearly identical
densities and are therefore difficult to resolve from each
other except under fractionation conditions where sedimen-
tation velocity is used.’5 Under the conditions used in the
previous reports of Mol subcellular localization, the second-
ary granule fraction was probably contaminated with gelati-
nase-containing organelles, since the fractionation technique
involved density separation.9’#{176} Taken together, these obser-
vations raise the possibility that Mol may reside in the
gelatinase-containing organelles.
To test this possibility, Mol surface expression under a
variety of conditions was compared to the extracellular
release of the contents of primary and secondary granules as
well as the gelatinase-containing organdIes. Two stimuli
were employed, fluoride and FMLP. Fluoride has been
previously shown to stimulate the respiratory burst in neutro-
phils without the concomitant release of markers of either
primary granules (myeloperoxidase, fl-glucuronidase, lyso-
zyme) or secondary granules (lysozyme, vitamin B,2 binding
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protein IB,2BP]).’6”7 FMLP at low concentrations causes
substantial release of gelatinase with minimal release of
primary and secondary granule contents.’5’8 The results
reported here indicate that both of these stimuli cause
substantial Mol expression and that this is correlated with
release of gelatinase but not markers for the primary and
secondary granules.
MATERIALS AND METHODS
Chemicals. Sodium fluoride, sodium chloride, and dimethyl
sulfoxide (DMSO) were purchased from Fisher Scientific, Fairlawn,
Ni. 3H-acetic anhydride and (57Co)-vitamin B,2 (90 cpm/pg) were
purchased from Amersham, Arlington Heights, IL. lonophore
A23187 (Calbiochem, LaJolla, CA), FMLP (Calbiochem), and
cytochalasin B (Sigma, St. Louis) were dissolved in DMSO and then
added to aqueous solutions with vigorous mixing. All other reagents
were purchased from Sigma, St. Louis, unless otherwise stated.
Monoclonal antibodies. Cell surface antigens were monitored
by indirect immunofluorescence analysis using monoclonal anti-
bodies (MoAbs) from mouse ascites specific for Mol (IgG-2a
subclass)5; fi-2 microglobulin (lgG-2b subclass), a gift of Dr Lee
Nadler, Boston’9; and Ia (lgG-2a subelass).￿#{176}
Cell preparation. Suspensions of PMNs were prepared from
acid citrate dextrose-treated blood by a previously reported proce-
dure.2’ Except for the step of sedimentation in dextran that was
performed at room temperature, cells were kept at 4#{176} C throughout
the preparation.
Cell stimulation. For FMLP and A23187 stimulation, cells
were diluted to 2 x 106 cells/mL in phosphate buffered saline
(PBS)22 (138 mmol/L NaCI, 2.7 mmol/L KCI, 8.1 mmol/L
Na2HPO4, 1.5 mmol/L KH2PO4, 0.9 mmol/L CaCI2, 0.5 mmol/L
MgCI2, and 7.2 mmol/L glucose, pH 7.4) and prewarmed to 37#{176} C.
Cells were incubated for five minutes at 37#{176} C with either FMLP
(concentrations ranging from l0_6 to l0￿ mol/L) or A23187 (106
mol/L). Cytochalasin B (10 Mmol/L) was added to some control
reaction mixtures to induce maximal degranulation. The total
concentration of DMSO (the solvent for cytochalasin B and FMLP)
never exceeded 2.5 izL/mL and had no effect on O2 production.
After incubation, reaction mixtures were transferred to an ice bath
and then centrifuged at 600 g for five minutes at 4#{176} C. The cells in
the pellets were used for Mol analysis and for determination of total
enzyme content, while the supernates were used for measurements of
enzyme release. For fluoride stimulation, a modified PBS (PBS’)
was used so that the final salt concentrations would be physiologic
after 20 mmol/L NaF (final concentration) was added.” The
nonstimulated cells in PBS’ received 20 mmol/L NaC1 to restore
isotonicity. During fluoride stimulation, cells were incubated for up
to 17 minutes at 37#{176} C with the samples taken at various times and
treated as described above for FMLP stimulated cells.
Measurements ofO2 production. Superoxide dismutase-inhib-
itable cytochrome c reduction was used to measure O2 as previously
reported23 except that the cytochrome c concentration was I 50
jzmol/L. Cells were prewarmed to 37#{176} C for two minutes prior to
stimulation and were used at a final concentration of 2 x 106
cells/mL in a final volume of I .9 mL. Cytochrome c was not limiting
as the maximum amount of O2 produced was 100.0 ± 6.5 nmol
(mean ± SD), which was less than the 150 nmol available for
reduction in the reaction mixture.
Immunofluorescent analysis of membrane antigens. Indirect
immunofluorescence of Mol and fl-2 microglobulin was measured
by flow cytometry as described by Todd et al.9 The channel number
(log scale) representing the mean fluorescence intensity of 5,000
cells, which had been exposed to either an experimental or a negative
control antibody (anti-Ia) and then to a fluorescein-conjugated goat
antimouse immunoglobulin, was determined. Logarithmic channel
numbers were converted to linear values,24 and the specific mean
fluorescence intensity for cells stained by experimental antibodies
was calculated by subtracting the mean channel number of cells
exposed to the negative control antibody from that ofcells stained by
the experimental antibodies. To compare data from one experiment
to another, the specific mean fluorescence of experimentally treated
cells was compared in each experiment to that resulting from
stimulation ofneutrophils with l06 mol/L A23l87 in the presence
of 10 Mmol/L cytochalasin B for five minutes at 37#{176} C, a value that
was defined as the maximum Mol expression.
Granule marker analysis. B,2BP was measured by a previously
reported modification’4 of the method of Gottlieb et al.25 MPO was
measured by the method of Bretz and Baggiolini.26 Lactic dehydro-
genase (LDH) was measured as previously described27 and was used
as a measure of cellular integrity during stimulation. The extent of
release of each of these markers was expressed as the percent of total
cellular activity present in the cell supernate following stimulation.
Gelatinase activity was measured by the release of tritium counts
from gelatin labeled with 3H-acetic anhydride by the method of
Dewald et al.’5 Before samples were assayed they were treated with 3
mmol/L di-isopropylphosphorofluoridate (DFP) to inhibit serine
proteases.’t Gelatinase-dependent tritium release was defined as the
difference between the total counts released by the extracellular
medium samples and the counts released in the presence of buffer
alone. Gelatin breakdown was found to be linear with substrate
concentration from 20 to 100 ￿g/mL, time from I .5 to 3.0 hours, and
cell concentration from 5 x l0￿ to 5 x 106 cells/mL. In a typical
assay containing substrate at a concentration of 20 ￿zg/mL (total
42,000 cpm) and supernates from cell suspensions (2 x 106 cells/
mL) incubated under various conditions, the following counts were
released from gelatin: unstimulated cells at 4#{176} C for five minutes, 90
cpm/ l0￿ cells; 37#{176} C for five minutes without stimulus, 360 cpm/ I0￿
cells; and 37#{176}C for five minutes with 106 mol/L A23l87 and 10
￿imol/L cytochalasin B, 1030 cpm/105 cells. The presence of an
inhibitor in the cytosol resulted in an inability to measure accurately
the total activity in the intact cell.28 Therefore, gelatinase release was
expressed not as percent release as with the other markers but
instead as the absolute amount of substrate degraded by the extra-
cellular fluid derived from the incubation of a fixed number of cells.
Maximum release was defined as the gelatinase activity present in
the extracellular medium following stimulation of neutrophils with
106 mol/L A23l87 and 10 ￿zmol/L cytochalasin B for five
minutes.
RESULTS
In Fig I the effects of temperature and fluoride on Mol
surface expression and gelatinase release are shown. The
data are expressed as the percent of maximum response
defined as that observed in the presence of A23 187 and
cytochalasin B. It can be seen that warming PMNs from
40 C to 37#{176} C resulted in a significant increase in both
gelatinase release (I .8-fold) and surface Mol expression
(1.8-fold) without concomitant release of MPO or B,2BP,
markers for the primary and secondary granules, respec-
tively. Subsequent stimulation of the prewarmed PMNs by
fluoride caused a further increase in gelatinase release
(1.85-fold) and in Mol expression (2.0-fold) above the 37#{176} C
control, again without release of primary or secondary
granules. Control experiments showed no release of LDH
(data not shown), indicating cellular integrity. In addition,
B,2BP and MPO could readily be detected by our assay
techniques when cells were exposed to A23 I 87 and cytochal-w
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asin B, indicating that failure to correlate fluoride-induced
Mol expression with granule release was not due to adher-
ence of the granule proteins to the cell surface. The levels of
MPO and B,2BP released were substantial and not statisti-
cally different from each other.
Experiments were then performed to determine the time
courses of Mol expression and gelatinase release following
fluoride stimulation. In addition, O2 production was mea-
sured simultaneously to see if its activation was correlated
temporally with either gelatinase release or Mol up-modula-
tion. As shown in Fig 2, both Mol surface expression and
gelatinase release rise concomitantly, beginning as early as
three minutes after the addition of fluoride and continuing
through the entire 16-minute incubation. In contrast, there
was no significant release of B,2BP and MPO under these
conditions. Superoxide production did not correlate with
either Mol expression or gelatinase release, as it began
substantially later after its characteristic nine-minute lag
period.’6”7 Thus the appearance of Mol on the cell surface
and the release of gelatinase were closely correlated in time
and appeared to occur independently of 02 production and
the release of primary and secondary granules.
Since Dewald et al have previously reported that chemo-
tactic concentrations of FMLP (l0￿ to 108 mol/L) cause
significant gelatinase release with minimal release of B,2BP
and MPO,’5 the effect of FMLP on Mol surface expression
was next determined. Figure 3 shows the effect of various
concentrations of FMLP on the expression of Mol and the
release of gelatinase. Increases in cell surface Mol and
gelatinase release occurred in parallel at all concentrations of
the stimulus except at the lowest concentration of FMLP
where the level of sensitivity of the gelatinase assay was
limiting and little or no gelatinase activity could be detected.
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Fig 1 . Fluoride stimulation of Mol expression and granule
marker release. PMNs were incubated in 20 mmol/L fluoride and
PBS’ for 15 minutes (￿) before Mol expression and enzyme
release were measured. NaCI was added to unstimulated cells at
4’ C () and at 37’ C (￿￿:.:) to bring the PBS’ to isotonicity. The
brackets indicate the SEM for six experiments. The maximum
response was defined as the amount of activity measured after
cells were incubated with l0 mol/L A23187 and 10 ￿smoI/L
cytochalasin B for five minutes. Average maximum values ( ± SEM)
are as follows: gelatinase, 1028 ± 295 cpm / 1O￿ cells; Mol . 1 30 ±
29 mean fluorescence units/cell (arbitrary units); B12BP release.
39% ± 9.2% of total cell B12BP; and MPO release, 53.5% ± 4.5% of
total cell MPO. #{149}P < 0.006 by paired t test for 4’ C v 37’ C and
37’ C v ￿r . tDifference is not significant for 37’ C v Fl
Fig 2. Time course of Mol expression. superoxide production,
and release of gelatinase, B12BP, and MPO following fluoride
stimulation. Mel expression (U). gelatinase release (#{149}). O￿ pro-
duction (A), BI2BP release (0). and MPO release (0). were
measured at various times after fluoride (20 mmol/I) had been
added to 2 x ￿ PMNs/mI at 0 minutes. The data from four
experiments are expressed as percentage of maximum response
(cells exposed at 10’ mol/I A23187 and 10 g&mol/I cytochalasin
B for five minutes) ± SEM. The values for the unstimulated control
did not change during the course of the incubation and were
subtracted from the fluoride measurements. The maximum
responses ( ± SEM) were as follows: for Mol . 98 ± 43 mean
fluorescence units/cell; for gelatinase release. 1 .035 ± 316 cpm/
￿ cells; for B,2BP release 47% ± 6% of total cell activity; for MPO
release 48% ± 9% of total cell activity; and for O￿ production.
108 ± 10 nmol/min/l x lO￿ cells (initial velocity).
Fig 3. The effect of FMIP concentration on Mol expression.
02 production, and release of gelatinase. B12BP, and MPO. Sepa-
rate aliquots of PMNs at 2 x 10’ cells/mI were exposed to
different concentrations of FMIP (l0’ to lO’ mel/I) for five
minutes at 37’ C and assayed for Mol expression. 02 production.
and enzyme release as described in ￿Methods.’￿ Activity in unstim-
ulated cells incubated at 37’ C for five minutes was subtracted
from the values obtained with stimulated cells. The data from four
experiments are expressed as the mean ± SEM for: Mol expres-
sion (U). in arbitrary mean fluorescence units; gelatinase release
(#{149}). in cpm/lO’ cells; 02 production (A). in nmol/min/l07 cells;
and for granule marker release [B12BP (0) and MPO (0)] in
percentage of total cell activity.608 PETREQUIN ET AL
At l0￿ mol/L FMLP, Mol expression and gelatinase
release were nearly maximal, while there was insignificant
release of both B12BP and MPO. Only at higher concentra-
tions of FMLP (10￿￿ mol/L) was the release of primary or
secondary granule contents observed. In all cases minimal
LDH was released (data not shown). As with MPO and
B12BP release, higher concentrations of FMLP (greater than
2.5 x l08 mol/L) were required to activate 02 production.
Thus increases in the expression of Mol on the cell surface
and the release of gelatinase were closely correlated at all
concentrations of FMLP and could be dissociated from 02
production and from release of primary and secondary
granules.
DISCUSSION
Our data suggest that human PMNs exhibit at least three
levels of activation with respect to Mol expression and
exocytosis. Upon intense stimulation (eg, with A23l87 and
cytochalasin B), substantial amounts of Mol are expressed
on the cell surface while secondary granules, primary gran-
ules, and gelatinase-containing organelles all release their
contents into the extracellular medium. At the other
extreme, in which the cells are in their basal or unstimulated
state (defined experimentally as PMNs maintained at 4#{176} C),
only 10% as much Mol is expressed and little, if any,
exocytosis occurs. An intermediate state of activation can
also be identified, perhaps part of a continuum of the
activation process, in which approximately 50% of the maxi-
mal Mol is expressed on the cell surface and in which only
the gelatinase-contai fling organelles undergo appreciable
exocytosis. Stimuli such as fluoride and FMLP (at low
concentrations) cause this intermediate level of activation
and provide an experimental system for correlating Mol
expression with exocytosis of gelatinase-containing or-
ganelles.
We provide here strong evidence that in the basal and
intermediate levels of activation, Mol expression is not
related to the release of primary or secondary granules.
When maintained at 4#{176} C, neutrophils express Mol without
any ongoing exocytosis, indicating that there is a certain
amount of Mol already present in the plasma membrane.
With fluoride as a stimulus, Mol expression increases to
approximately 50% of its maximum without any net increase
in the release of B12BP or MPO (Figs 1 and 2). These data
are consistent with previous reports demonstrating absence
of primary and secondary granule release in response to
fluoride.’6”7 Similar results were obtained with FMLP at
concentrations below 1O￿ mol/L where more than 50% of
the Mol is expressed with less than 10% release of the
primary and secondary granules.15 Taken together these data
indicate that the primary and secondary granules do not
contain the intracellular reserves of Mol that are expressed
in the intermediate state(s) of PMN activation.
If this labile reserve pool of Mol is not located in the
primary and secondary granules, where is it located? One
possibility would be cryptic sites within the plasma mem-
brane that are exposed following stimulation. This, however,
does not appear to be the case based on two findings in
previous reports.9”3 The first observation was that the Mol
antigen was found to be located predominantly in a second-
ary granule-containing fraction and present only in small
amounts in the plasma membrane fraction.9”3 The second
was that immunofluorescent staining of PMNs with the Mol
antibody showed a granular intracellular staining pattern.’3
Based on these studies it would appear that the Mol reserve
pool is located within the cell and not in the membrane. Two
observations in the literature suggest that the gelatinase-
containing organelles may be one major intracellular site.
First, gelatinase-containing organelles have a density nearly
identical to that of the secondary granules and would there-
fore co-purify on density gradients with the secondary gran-
ule fraction that reacts with Mol ￿9,l0,l3,l5 Second, the gelati-
nase-containing organelles are quite labile and readily fuse
with the plasma membrane upon warming or gentle stimula-
tion, properties that are strikingly similar to the Mol expres-
sion seen in the intermediate stages of activation. We now
provide data showing a strong correlation between Mol
expression and the fusion of gelatinase-containing organelles
with the plasma membrane. With fluoride, the time course of
Mol expression and gelatinase release closely parallel each
other, while in the FMLP experiments, the dose-response
curves for Mol and gelatinase are strikingly similar. In
quantitative terms, fluoride causes the release of 60% of the
releasable gelatinase, a value that agrees closely with the
50% maximal Mol expression induced by this stimulus. A
similar quantitative relationship is observed with FMLP.
Thus the intermediate level of Mol expression occurs in the
absence of primary and secondary granule release and
strongly correlates with exocytosis of the gelatinase-contain-
ing organelles.
Since approximately 50% of the maximal Mol is
expressed under conditions where roughly 50% of the maxi-
mal gelatinase is released, it is tempting to speculate that the
remaining Mol is also located in the gelatinase-containing
organelles. Because of the lack of specificity of the gelatinase
assay, however, the possibility that some Mol is located in
the secondary granules cannot be excluded. The substrate
employed in the gelatinase assay (derived from type I
collagen) can be degraded by neutrophil collagenase29 pres-
ent in the secondary granules3#{176}as well as by elastase in the
primary granules.3’ Experimental conditions which result in
maximum Mol expression (A23I87 + cytochalasin B) also
cause the release of substantial amounts of primary and
secondary granule contents.’2 The collagenase and elastase
thus released contribute to the total gelatinolytic activity and
make it difficult to determine the contribution of the gelati-
nase-containing organelles. Because of these technical limi-
tations, the most that can be concluded from the data is that
at least 50% of the Mol that is eventually expressed is
contained in the gelatinase-containing organelles. Whether
the remaining 50% is localized to the same organelles or to
the specific granules can only be determined by direct
measurements of Mol in subcellular fractions in which
specific granules are resolved from the gelatinase-containing
organelles. This, however, requires the sophisticated technol-
ogy of rate zonal sedimentation.
The possibility that at least some of the intracellular poolREFERENCES
Mol EXPRESSION AND GELATINASE RELEASE 609
of Mol is contained in the specific granules is supported by
studies on a patient with specific granule deficiency.’3 Mol
expression in these experiments was determined by measur-
ing the number of C3bi receptors on the cell surface. PMNs
from the patient exhibited abnormal up-regulation ofC3bi in
response to stimulation, suggesting a specific granule loca-
tion for at least part of the Mol. Whether the gelatinase-
containing organelles in this patient were also abnormal,
however, was not reported.
Mol expression does not appear to be sufficient to activate
02 generation. In both the fluoride and FMLP experiments,
substantial amounts of Mol were expressed without concom-
itant O2 generation. We cannot exclude the possibility,
however, that Mol might still be necessary for respiratory
burst activation, since we have not observed O2 production
in the absence of Mol up-regulation.
The localization ofat least 50% ofthe intracellular Mol in
the labile gelatinase-containing organelles may have physio-
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logic relevance. During chemotaxis when PMNs are exposed
to low concentrations of chemotactic agents like FMLP,
gelatinase-containing organelles will fuse with the plasma
membrane and cause increases in both the amount of Mol
expressed on the cell surface and the amount of gelatinase in
the extracellular medium. This increase in Mol would
enhance PMN attachment to surfaces, a necessary step
required for efficient chemotaxis of PMNs through tissues.
The gelatinase could serve to partially degrade connective
tissue that might impede the mobility of the PMNs. Finally,
this early deployment of Mol would also eventually facilitate
recognition and ingestion of microbes opsonized with C3bi,
since it also functions as the C3bi receptor.
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